Adjunctive Mood Stabilizer and Benzodiazepine Use in Older Asian Patients with Schizophrenia, 2001–2009
Yu‐Tao Xiang(University of Macau), Naotaka Shinfuku(Seinan Gakuin University), Norman Sartorius(The Geneva Association), Faith Dickerson(Sheppard Pratt Health System), Yiqun He(Shanghai Mental Health Center), Ee Heok Kua(National University of Singapore), Shuyu Yang(Amway (United States)), Senta Fujii(Hyogo Institute for Traumatic Stress), Tianmei Si(Peking University), Julie Kreyenbuhl(University of Maryland, Baltimore), Kang Sim(National University of Singapore), Kok Yoon Chee(Hospital Kuala Lumpur), Michelle K. Yong(The University of Melbourne), Chuanyue Wang(Capital Medical University), Edwin Lee(Center For Balanced Living), C.H. Tan(Netherlands Organisation for Applied Scientific Research), Hsin‐Yi Chiu(Chinese University of Hong Kong), Jitendra K. Trivedi, Pichet Udomratn(Prince of Songkla University), E.-K. Chung(Chinese University of Hong Kong), Mian‐Yoon Chong(Chang Gung University)
Cited by 15
Related Papers
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
Reduced default mode network functional connectivity in patients with recurrent major depressive disorder
|Proceedings of the National Academy of Sciences|2019|865
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
|Schizophrenia Bulletin|2004|768
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714